Precision BioSciences has just unveiled its plans for a public offering of common stock and warrants on February 29, 2024. The specific details of the offering have not yet been made public. This announcement comes on the heels of a recent underwritten offering of common stock, where shares were sold at $1.39 each, generating around $50 million in total gross proceeds. The new offering also includes a provision for underwriters to purchase an additional 15% of the total shares and warrants within a 30-day window. Jefferies has been appointed as the exclusive book-running manager for this offering. The company has stated that the completion and allocation of proceeds from the offering are part of its forward-looking statements.
DTIL Stock Faces After-Hours Drop: Investors Keep Close Eye on Performance
On February 29, 2024, DTIL stock experienced a slight decrease in its price momentum. The stock closed at $18.50, marking a $0.06 decrease from the previous market close, representing a 0.32% drop. After hours, DTIL stock dropped a significant $4.02, further impacting its overall performance. This after-hours drop could be attributed to various factors, such as market volatility, company news, or investor sentiment. Investors and analysts will be closely monitoring DTIL’s performance in the upcoming days to see if the stock can recover from this after-hours drop. It will be interesting to see how DTIL navigates through these challenges and whether it can regain its momentum in the market.
DTIL Stock Plummets in Total Revenue, Net Income, and EPS on February 29, 2024
On February 29, 2024, DTIL stock experienced a significant decrease in total revenue compared to the previous year and the previous quarter. According to data from CNN Money, the total revenue for DTIL was $25.10 million in the last year, but it dropped by 78.28% to $13.12 million in the third quarter. The net income for DTIL also saw a decline, with a net loss of $111.64 million in the last year and a net loss of $12.11 million in the third quarter. Earnings per share (EPS) for DTIL also took a hit, with an EPS of -$38.10 in the last year and an EPS of -$4.30 in the third quarter. Overall, DTIL stock performances on February 29, 2024, showed a downward trend in total revenue, net income, and earnings per share. Investors may want to closely monitor the company’s financial performance and future outlook before making any investment decisions.
